Interleukin‑6 (IL‑6) Mini Panel Test in UAE – 750 AED | Precision Cytokine Biomarker

Executive Summary & Core Metrics

✓ Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited dual‑method processing (ECLIA + immunoturbidimetry).

✓ Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, available daily from 8 AM to 11 PM.

✓ Clinical Guidance: Telephonic post‑test consultation for result interpretation.

✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Data privacy protected under UAE PDPL (Federal Decree‑Law No. 45 of 2021) and Federal Law No. 2 of 2019 on health ICT; all testing follows ISO 9001:2015 and DHA/MOHAP standards. Clinical safety governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Test Overview & Methodology

The Interleukin‑6 (IL‑6) Mini Panel is a precision cytokine test that quantifies IL‑6, a master regulator of inflammation, using high‑sensitivity electrochemiluminescence immunoassay (ECLIA) with immunoturbidimetric confirmation. This panel aids general physicians, wellness directors, and anti‑aging specialists in evaluating systemic inflammatory burden, cardiovascular risk, and therapy response.

Feature	Our IL‑6 Mini Panel (ECLIA + Immunoturbidimetry)	Standard IL‑6 ELISA
Precision	99.9% sensitivity; dual‑method validation	Variable sensitivity (80–95%) depending on kit
Methodology	Electrochemiluminescence (ECLIA) + immunoturbidimetric confirmation	Enzyme‑linked immunosorbent assay only
Turnaround Time	Same‑day report (sample received by 4 PM)	24–48 hours
Home Collection	ISO cold‑chain VIP mobile phlebotomy, 8 AM–11 PM	Often lab‑only with standard courier

Physician Insight & Safety Protocols

"Interleukin‑6 is a pivotal sentinel of the body’s inflammatory network. I remind every patient that a single laboratory value never stands alone – it must be woven together with your symptoms, physical examination, and other biomarkers to paint the full clinical picture. Please never adjust therapy based solely on this result."

— Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)

Medication Advisory

Medication Warning

Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of anti‑inflammatory or immunomodulatory drugs can precipitate disease flares.

Exclusion Criteria & Red Flags

Biotin interference: Do not take high‑dose biotin (>5 mg) within 8 hours before collection.
Bleeding risk: Patients with severe coagulopathy or anticoagulant therapy require prior physician clearance.
Acute emergency signals: If you experience crushing chest pain, difficulty breathing, confusion, or fever above 38.5°C, seek immediate emergency care – do not rely on this test alone.

This panel supports chronic inflammation monitoring. It is not a substitute for urgent clinical evaluation.

Patient FAQ & Clinical Guidance

1. What is the Interleukin‑6 Mini Panel and why is it ordered?

The IL‑6 Mini Panel uses high‑sensitivity electrochemiluminescence to measure your blood’s interleukin‑6 level, a key driver of systemic inflammation and cardiovascular risk. It helps detect hidden inflammation, monitor autoimmune conditions, and guide longevity programs. Physicians order it alongside CRP and other markers for a comprehensive inflammatory profile.

2. How should I prepare for the IL‑6 Mini Panel blood draw?

For accurate results, avoid biotin supplements for at least 8 hours, maintain overnight fasting, and complete the mandatory Coagulation Requisition Form (Form 15). Our phlebotomist will collect one lavender‑top (EDTA) tube and one blue‑top (citrate) tube; the citrate sample must be processed quickly to obtain platelet‑poor plasma.

3. How quickly will I get my results and what do elevated IL‑6 levels mean?

Results are reported the same day when the laboratory receives your sample by 4 PM; elevated IL‑6 requires clinical correlation with your symptoms and other tests. Slightly high levels may reflect obesity or stress, while markedly elevated values can indicate infection, autoimmune flare, or cytokine release syndrome. Always discuss results with your physician.

UAE Regulatory & Data Privacy Adherence

This test and all associated data handling comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License 1143 and operates under ISO 9001:2015 certification.

Clinical & Logistical Metadata

Test Name	Interleukin‑6 (IL‑6) Mini Panel
Price (AED)	750
Turnaround Time	Same‑day report (sample received by 4 PM)
Sample Type / Matrix	Serum or Plasma (EDTA and Citrate tubes)
Methodology Used	Electrochemiluminescence immunoassay (ECLIA) with immunoturbidimetric confirmation
ICD‑10‑CM Code	R79.89 (Other specified abnormal findings of blood chemistry)
LOINC Code	33862‑6 (Interleukin 6 [Mass/volume] in Serum or Plasma)
DHA Facility License & Laboratory Address	DHA License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE